Ibovespa Futuro trades between profit and loss with stimulus-conscious investors in the US.

SÃO PAULO – Ibovespa Futuro opens between profit and loss on Thursday (22) with the continuing uncertainties surrounding the negotiations for a stimulus package in the United States. Yesterday, the spokeswoman for the US House of Representatives, Nancy Pelosi, said that she and the Secretary of the Treasury, Steven Mnuchin, spoke for 48 minutes and were closer to signing an agreement.

At the beginning of the pandemic, the United States spent $ 3 trillion to address the economic impacts of Covid-19. In recent weeks, the Trump administration proposed releasing $ 1.9 trillion this time. However, the most recent proposal for representatives of the Democratic Party, which has a majority in Congress, is around $ 2.2 trillion.

Here, in politics, there is still the unfolding of the speech of Jair Bolsonaro (not party) on Wednesday on Twitter when the president disavowed the Minister of Health, General Eduardo Pazuello, who announced an agreement to buy vaccines that will be produced in São Paulo for the Butantan Institute in association with the Chinese Sinovac.

At 09:10 AM (Brasilia time), the future index for December had a slight increase of 0.13%, at 100,835 points.

The US dollar maturing in November registered a slight negative variation of 0.04%, to R $ 5,608.

In the future interest market, the DI of January 2022 rises two basis points to 3.26%, the DI of January 2023 rises two basis points to 4.60%, the DI of January 2025 advances two basis points in 6.40% and the DI of January 2027 registered a positive variation of two basis points at 7.30%.

Also on the radar, US National Intelligence Director John Ratcliffe told a news conference that “Iran and Russia have taken specific actions to influence public opinion regarding the elections.”

Both countries obtained separate information on US voters. According to Ratcliffe, the data can be used to try to communicate false information to voters, in an attempt to cause confusion and chaos, undermining trust in American democracy.

On Thursday, the Kremlin denied US allegations that it attempted to interfere in this year’s US presidential elections, calling them unfounded.

Bolsonaro criticizes the Chinese vaccine

The political news should follow on Thursday the movements of the federal government and the federal government regarding the vaccine being tested by the Chinese laboratory Sinovac in the state of São Paulo, in association with the Butantan institute.

On Wednesday, President Jair Bolsonaro (without a party) dismissed the speech of the Minister of Health, General Eduardo Pazuello, who announced the purchase of 46 million doses of the vaccine. On Twitter, Bolsonaro wrote in capital letters that the vaccine “WILL NOT BE PURCHASED.”

He responded to a netizen who said he wanted to have “a future, but without interference from the Chinese dictatorship.” Another netizen claimed that Pazuello had betrayed him with the agreement, and Bolsonaro replied that “everything that is published, without proof, becomes BETRAYAL.”

On Tuesday (20), at a meeting of the Governors’ Forum, Minister Pazuello had announced that he had signed a protocol of intent to purchase 46 million doses of the Sinovac vaccine. At the time, the minister referred to the vaccine as “the Brazilian vaccine.”

The speech temporarily dispelled fears on the part of state health secretaries and health ministry technicians that the federal government would relegate the Chinese vaccine for political reasons.

The governor of São Paulo, João Doria (PSDB), is considered a potential presidential candidate for the 2022 elections, and his stance to combat the coronavirus contradicts the presidential stance since the beginning of the pandemic.

Although Bolsonaro ruled out the Chinese vaccine in his tweets, the Ministry did not break the deal to buy the vaccine, with an estimated value of R $ 1.9 billion.

Another point of disagreement is over the mandatory vaccine. Doria says that vaccination will be mandatory in São Paulo, Bolsonaro says it will not be mandatory at the federal level.

The Sinovac vaccine is in the third and final phase of testing. The federal government is also testing the vaccine from the pharmaceutical company AstraZeneca in Brazil in partnership with the University of Oxford in the UK. It is also in the final testing phase and should be produced in Brazil by Fiocruz in Manguinhos, in Rio de Janeiro.

The government must also buy the vaccine produced by the Covax Facility (Covid-19 Global Vaccine Access Instrument), a global consortium that has been developing 9 different vaccines, to which Brazil will have access.

On October 18, the Ministry of Health reported that it paid R $ 830.9 million to join the Covax Facility. In total, the government announced the purchase of 186 million vaccines for the first half of 2021.

After the presidential tweets, Doria said on Wednesday night that the governors intend to wait at least until Friday (23) to take any action on the president’s decision. He would have the support of state health secretaries, Doria said it is possible to take the matter to the Federal Supreme Court.

Vote for vetoes

The president of the Senate, Davi Alcolumbre (DEM-RJ), said that he will govern all presidential vetoes pending analysis in the November 4 session.

Among them, there will be vetoes for the extension of the payroll tax exemption and extracts from the New Legal Framework for Sanitation.

“The vote in the Congress session provides for the vote on the exemption veto. I intend to put all the pending bills of the National Congress on the agenda and all the vetoes, ”he said. “I hope we get the correct number both in the House and in the Senate to begin the session of Congress,” he said Wednesday night, 21, leaving plenary.

Corporate radar

Oil company Enauta is taking advantage of the slowdown in the sector to buy fields on land and on the Brazilian coast. JBS approved the raising of R $ 2 billion in debentures for the purchase of livestock.

The Eletrobras meeting approved Eletronuclear’s capital increase of R $ 1.88 billion in the quarter. Credit Suisse started this fifth Vitru hedge, with a neutral assessment (earnings in line with the market average).

The Federal Police are investigating an alleged fraud in Infraero that involves the tendering of commercial areas in Congonhas and Santos Dumont. The recipients are public agents linked to Infraero and entrepreneurs. Frauds could have reached R $ 10 million, between 2016 and 2018. Oleoplan, a biodiesel manufacturer, requested in the fourth registration to carry out its initial public offering of shares.

(With Bloomberg and Agência Estado)

The free InfoMoney series explains the right time to enter and exit assets in the stock market – click here and learn how to beat the market sharks consistently and safely